FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14189611000001100: Bicalutamide 150mg tablets (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50663301000001119 Bicalutamide 150mg tablets (AstraZeneca) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54102901000001114 Bicalutamide 150mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bicalutamide 150mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Is a Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has active ingredient Bicalutamide false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has specific active ingredient Bicalutamide true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bicalutamide 150mg tablets (AstraZeneca) 28 tablet 2 x 14 tablets Is pack of False Bicalutamide 150mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has AMP True Bicalutamide 150mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start